• Crystal structure of the thalidomide analog (3aR∗,7aS∗)-2-(2,6-dioxopiperidin-3-yl)hexahydro-1H-isoindole-1,3(2H)-dione 

      Hijji, Yousef; Benjamin, Ellis; Jasinski, Jerry P.; Butcher, Ray J. ( International Union of Crystallography , 2018 , Article)
      The title compound, C13H16N2O4, crystallizes in the monoclinic centrosymmetric space group, P21/c, with four molecules in the asymmetric unit, thus there is no crystallographically imposed symmetry and it is a racemic ...
    • (E)-2-{[(Furan-2-ylmethyl)imino]methyl}-4-nitrophenol 

      Hijji, Yousef; Azemati, Samira; Butcher, Ray J.; Jasinski, Jerry P. ( International Union of Crystallography , 2014 , Article)
      In the title compound, C12H10N2O4, the furan-2-ylmethyl group is disordered over two sets of sites, with refined occupancies of 0.858 (3) and 0.143 (3). In the major component of disorder, the dihedral angle between the ...
    • (E)-2-{[4-(dimethylamino)benzylidene]amino}-5-nitrophenol 

      Hijji, Yousef; Butcher, Ray J.; Jasinski, Jerry P. ( International Union of Crystallography , 2014 , Article)
      The title Schiff base compound, C15H15N 3O3, crystallizes with two molecules (A and B) in the asymmetric unit. Each molecule adopts an E conformation around the C= N imine bond. The two molecules have minor differences in ...